pancreatic-cancer

Documents about pancreatic-cancer

• A 2-part Phase 1/2 Open-label Trial on ODM-212#865003ClinicalTrials.gov
• Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy#868920ClinicalTrials.gov
• Food Reward in Cachexia Induced by Acute or Chronic Disease#879608ClinicalTrials.gov
• Improving Goals of Care Discussion in Advanced Cancer Patients#885611ClinicalTrials.gov
• Computational design and molecular characterization of a multi-epitope peptide vaccine targeting pancreatic cancer.#67442NCBI PubMed Central
• Toward precision chemotherapy in pancreatic ductal adenocarcinoma: molecular, transcriptomic and clinical determinants#159273HAL (France)
• Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells#185686IRIS
• Stress-induced CXCL13 regulates pancreatic exocrine homeostasis, age-related chronic inflammation, and cancer progression#235450Kyoto University Research Information Repository
• From tumor metabolism to brain circuits: METTL14 as a SAM sensor driving pain-depression in pancreatic cancer.#242193NCBI PubMed Central
• Multi-stromal organoid co-cultures model pancreatic cancer and pancreatitis epithelial cell-fibroblast heterogeneity#367255Europe PMC
• Surgical Apgar Score After Whipple Procedure in Pancreatic Cancer Patients#802399ClinicalTrials.gov
• Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer#805269ClinicalTrials.gov
• Virtual Mind-Body Exercises for People Having Pancreatic Surgery#830188ClinicalTrials.gov
• Phase IIT Trial of SNA014#898016ClinicalTrials.gov
• A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas#895041ClinicalTrials.gov
• Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma#865303ClinicalTrials.gov
• A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up#867129ClinicalTrials.gov
• Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction#893825ClinicalTrials.gov
• Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers#806495ClinicalTrials.gov
• Nutritional Intervention Implication in Enhanced Recovery After Surgery for Whipple Procedure#802658ClinicalTrials.gov
• Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas#858950ClinicalTrials.gov
• Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer#862503ClinicalTrials.gov
• Combined Association of Time to Treatment, Guideline Concordance, and Neighborhood Vulnerability with Localized Colon Cancer, Non-small-cell Lung Cancer, and Pancreatic Cancer Survival#345886Springer Nature OA
• Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors#884251ClinicalTrials.gov
• Study of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid Tumors#840056ClinicalTrials.gov
• A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma#394772ClinicalTrials.gov
• Federated CT foundation models for multi-center detection of lymph node metastasis in pancreatic cancer.#3919NCBI PubMed Central
• Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identification#157799Unpaywall
• Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B#272353ClinicalTrials.gov
• Targeting WFS1 overcomes KRAS(G12D) dependency and adaptive resistance to KRAS inhibition in pancreatic cancer.#298906NCBI PubMed Central
• Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer#347596Harvard DASH
• Algorithmic implementation of pancreatic cancer staging guidelines: comparison with a retrieval-augmented large language model#417374bioRxiv / medRxiv
• Active learning-guided mechanistic modeling reveals context-specific regulators of CXCL9 expression in pancreatic cancer cells.#430832NCBI PubMed Central
• Hypoxia-induced metastatic heterogeneity in pancreatic cancer#484996Europe PMC
• Artificial Intelligence-Estimated Intrapancreatic Fat and Its Relationship to Familial and Germline Pancreatic Cancer Risk.#615722NCBI PubMed Central
• miR-27b-5p targets RAB27A to regulate exosome secretion and migration of pancreatic cancer cells.#685543NCBI PubMed Central
• Resistance mechanisms in response to dual SHP2 and MAPK/KRASG12D inhibition in pancreatic cancer#784078Deutsche Nationalbibliothek
• A Metal-Free Carbon Monoxide Prodrug Suppresses Metastasis of Pancreatic and Breast Cancer#657804Cornell eCommons
• Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors#824951ClinicalTrials.gov
• Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors#812228ClinicalTrials.gov
• A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations#838499ClinicalTrials.gov
• VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma#136329ClinicalTrials.gov
• Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents#834013ClinicalTrials.gov
• Association of menstrual and reproductive factors with pancreatic cancer risk in women : findings of the Japan Collaborative Cohort Study for Evaluation of Cancer Risk#384168CiNii
• NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors#810456ClinicalTrials.gov
• Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors#195334ClinicalTrials.gov
• The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma#634722eScholarship
• Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors#839793ClinicalTrials.gov
• [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications#826631ClinicalTrials.gov
• Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects#846380ClinicalTrials.gov